There will be increased drug testing at Wimbledon, according to *Reuters*, with UK Anti-Doping (UKAD) receiving extra funding from the All England Club to conduct the testing.
The news agency said the International Tennis Federation confirmed that the All England Club had organized to fund extra testing by UKAD, and that there had been discussions between the ITF and the tournament about the measures.
The ITF, which runs the tennis anti-doping program, will administer its usual in-competition testing. It indicated that UKAD will concentrate on testing players in the run-up to the tournament and at other times during the competition.
In a pre-event press conference, Wimbledon said it would step up anti-doping for the tournament, but did not give details. In a statement to Reuters, it confirmed it "will be implementing additional anti-doping measures for The Championships," but the "details are required to remain confidential" and testing will, as usual, be conducted independently of tournament organizers.
The amount of additional funding was not revealed. The tennis anti-doping program has been estimated to receive about $4 million annually, jointly provided by the ATP and WTA tours, the ITF and the Grand Slams.
The Australian Open had an unprecedented level of drug testing for a Grand Slam, the Daily Mail previously revealed, reporting that every singles player at the event was tested and 450 blood tests were taken.
Wimbledon also announced additional measures to combat any attempts at match-fixing, including taping all qualifying matches for analytical purposes, if necessary.
The tournament also announced a 5 percent increase in prize money, with 2 million pounds awarded to the singles winners.